Blog
New study finds alcohol-related liver disease on rise in young adults
Good summary from the folks at WITN-- https://youtu.be/Zp6p7TKT_hQ?si=IlxDM79XOaPOh7je
Efruxifermin reverses MASH-related cirrhosis in Phase 2
Efruxifermin reverses MASH-related cirrhosis in Phase 2 trial, per a recent press release from Akero Therapeutics. Treatment with Akero Therapeutics’ investigational efruxifermin led to reversals of compensated cirrhosis, or irreversible scarring in a...
Protecting PrEP Testing
From Contagion Live on 03/04/2025:"Last week, 20 HIV and hepatitis organizations filed an amicus brief with the Supreme Court in support of the US government’s position in Kennedy v. Braidwood Management, which challenges the Affordable Care...